Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05601804 · ClinicalTrials.gov registry record

TARGETing Healthy Weight Loss in the Context of Food Insecurity

A clinical trial of Obesity and Food Insecurity, sponsored by Pennington Biomedical Research Center.

Active
Registry status
45
Enrollment target
1
Study location

NCT05601804: Active study of Obesity and Food Insecurity, sponsored by Pennington Biomedical Research Center.

NCT05601804 is a study of Obesity and Food Insecurity that is active but no longer recruiting, run by Pennington Biomedical Research Center. The registered enrollment target is 45 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05601804, a study of Obesity and Food Insecurity, is active but no longer recruiting, sponsored by Pennington Biomedical Research Center.

ACTIVE NOT RECRUITING
Registry status
45 participants
Enrollment target
1
Study location

Study Summary

This pilot and feasibility study will collect information from food insecure, as well as food secure, women with obesity to detail their desires and needs for healthy weight reduction. Up to 60 women with obesity will be enrolled. Pennington Biomedical Research Center will coordinate this qualitative study and use focus groups discussion to collect formative data.

Primary Outcome

Via focus group discussions, we will elicit in-depth information from women with food insecurity and obesity to detail their desires and needs for weight loss.

Study Locations (1)

Louisiana

  • Pennington Biomedical Research Center - Baton Rouge

Trial Details

FieldValue
Enrollment Target 45 participants
Start Date 2022-09-01
Est. Completion 2025-12-31

What the registry record for NCT05601804 still lists

NCT05601804 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (95% lower).

The record links to 4 conditions, with Obesity appearing as the primary indexed condition, and to 0 interventions.

NCT05601804 reports a single indexed study location in Louisiana.

Frequently Asked Questions

What is clinical trial NCT05601804 about?

NCT05601804 is a clinical study titled "TARGETing Healthy Weight Loss in the Context of Food Insecurity". This pilot and feasibility study will collect information from food insecure, as well as food secure, women with obesity to detail their desires and needs for healthy weight reduction. Up to 60 women with obesity will be enrolled. Pennington Biomedical Research Center will coordinate this qualitativ...

What is the current status of trial NCT05601804?

This trial is currently active not recruiting. The enrollment target is 45 participants. The study started on 2022-09-01. Estimated completion is 2025-12-31.

What conditions does trial NCT05601804 study?

This clinical trial studies the following conditions: Obesity, Food Insecurity, Body Weight, Food Security.

Who is sponsoring clinical trial NCT05601804?

This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05601804 being conducted?

This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05601804's enrollment target sits among peer trials

45 752nd of 1053 higher than 295 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00804154 · 45 participants · Phase 1

    Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer

  • NCT01851694 · 45 participants · NA

    Beta-cell Response to Incretin Hormones in Cystic Fibrosis

  • NCT02896335 · 45 participants · Phase 2

    Palbociclib and Pembrolizumab In Central Nervous System Metastases

  • NCT03454035 · 45 participants · Phase 1

    Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05601804, the US trial registry maintained by the National Library of Medicine. NCT05601804 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.